Covid Reference

Page 154

154

|

CovidReference.com

novel SARS-CoV and MERS-CoV. There is strong evidence that these viruses emerged recently from animal reservoirs, originating in bats and transmitted to man via intermediate host species. Intra- and inter-species transmission of CoVs, and genetic recombination events contribute to the emergence of new CoV strains. The following sections will review CoV in general with a more detailed appraisal of the origin, evolution, virological structure and pathogenesis of SARS-CoV-2 to expand knowledge pertaining to COVID-19 and prospective anti-viral and vaccine therapies.

History Coronavirus disease was first described as early as 1930 presenting as infectious bronchitis in chickens, gastroenteritis in pigs and severe hepatitis and neurological disease in mice. The first coronavirus to be isolated was the Infectious bronchitis virus (IBV) from chickens with respiratory disease reported by Beaudette and Hudson in 1937 (Zuckerman 2009, Korsman 2012, Knipe 2013). The first human coronaviruses were discovered much later. In 1965, Tyrrell and Bynoe isolated a virus, which they designated B814, from a respiratory tract sample of a boy with a common cold by passage in embryonic tracheal organ cultures (Zuckerman 2009). At the same time, Hamre and Procknow were able to grow a virus, designated 229E, in tissue culture from samples obtained from medical students with upper respiratory tract infections. These two viruses were both ether-sensitive, shared identical morphology under electron microscope, and were not related to any known human viruses. Furthermore, B814 resembled avian IBV suggesting a similar origin (Perlman 2020, Kahn 2005). Following similar techniques of tissue culture, English scientist McIntosh and colleagues recovered multiple isolates of previously unknown pathogenic agents from human respiratory tract samples. The human viral prototype was designated OC43 indicating it was grown in organ culture (Perlman 2020, Kahn 2005). OC43 morphologically resembled two animal CoV, mouse hepatitis virus and transmissible gastroenteritis virus of swine. The unique feature were the distinct protruding spike proteins present on the viral surface reminiscent of a crown. This group of unrecognized viruses was thus named “Coronaviridae” which received and accepted by the International Committee for the Taxonomy of Viruses (ICTV) in 1968,. (Perlman 2020, Kahn 2005, Almeida 1968). In November of 2002 an unusual and lethal form of pneumonia, termed severe acute respiratory syndrome (SARS), emerged in Guangdong province, PeoKamps – Hoffmann


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

References

1hr
pages 497-554

Management

10min
pages 491-496

Diagnosis and classification

11min
pages 484-490

Transplantation

4min
pages 472-473

Transmission

4min
pages 482-483

Pathophysiology and immunopathology

4min
pages 480-481

Natural course and risk factors for complications

2min
page 479

Epidemiology of COVID-19 in children

2min
page 478

Cancer

8min
pages 468-471

Immunosuppression (other than HIV

3min
pages 466-467

HIV infection

6min
pages 463-465

COPD and smoking

4min
pages 461-462

Hypertension and cardiovascular co-morbidities

14min
pages 452-458

Diabetes mellitus

4min
pages 459-460

References

6min
pages 447-451

Special situations in severe COVID-19

3min
pages 445-446

References

25min
pages 429-440

Spotlight: The situation in a German COVID-19 hospital

4min
pages 443-444

Outlook and Recommendations

1min
page 428

4. Immunomodulators

19min
pages 415-424

Other treatments for COVID-19 (with unknown or unproven mechanisms of action

5min
pages 425-427

3. Monoclonal Antibodies and Convalescent Plasma

13min
pages 408-414

2. Various antiviral agents

5min
pages 405-407

1. Inhibitors of the viral RNA synthesis

11min
pages 399-404

Monitoring, treatment options

3min
pages 391-392

Studies with objectifiable tests

3min
pages 389-390

Reactivations, reinfections

2min
page 366

Outcome

27min
pages 352-365

Clinical classification

1min
page 351

Laboratory findings

6min
pages 347-350

References

21min
pages 324-332

Asymptomatic cases

4min
pages 334-335

Radiology

6min
pages 321-323

Incubation period

1min
page 333

Symptoms

21min
pages 336-346

Diagnosis

36min
pages 303-320

References

55min
pages 277-302

Outlook

5min
pages 272-276

Single Vaccines

24min
pages 247-261

Coming vaccines

8min
pages 267-271

Special Topics

9min
pages 241-246

Approved Vaccines

2min
pages 223-224

References

21min
pages 211-222

Outlook

1min
page 210

Transmission

1min
page 187

Epidemiology

11min
pages 175-186

Summary – 13 February

1min
page 173

Genomic Structure and Variation

4min
pages 164-166

References

8min
pages 167-172

Origin and Evolution

4min
pages 158-159

Introduction

1min
page 174

History

4min
pages 154-155

References

20min
pages 136-152

Conclusion

1min
page 135

Introduction

31min
pages 117-133

Containment or mitigation of COVID-19?

1min
page 134

References

40min
pages 99-116

Outlook

1min
page 98

Prevention

3min
pages 96-97

End of Quarantine

1min
page 95

Transmission Event

26min
pages 82-94

References

31min
pages 54-68

Summary

1min
page 69

Routes of Transmission

16min
pages 73-81

Outlook

3min
pages 52-53

The 2020 Lockdowns

7min
pages 48-51

Person-to-person transmission

2min
page 72

Special Aspects of the Pandemic

15min
pages 38-46

The SARS-CoV-2 pandemic: Past and Future

2min
page 47
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.